Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4882925> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q4882925 subject Q7427150.
- Q4882925 subject Q8515266.
- Q4882925 subject Q8824860.
- Q4882925 abstract "Belinostat (trade name Beleodaq, previously known as PXD101) is a drug developed by TopoTarget for the treatment of hematological malignancies and solid tumors. It is a histone deacetylase inhibitor.In 2007 preliminary results were released from the Phase II clinical trial of intravenous belinostat in combination with carboplatin and paclitaxel for relapsed ovarian cancer. Final results in late 2009 of a phase II trial for T-cell lymphoma were encouraging.Belinostat has been granted orphan drug and fast track designation by the FDA, and was approved in the US for the use against peripheral T-cell lymphoma on 3 July 2014. It is not approved in Europe as of Template:MONTHNAME 2014[[Category:Articles containing potentially dated statements from Template:MONTHNAME 2014]].".
- Q4882925 bioavailability "100.0".
- Q4882925 thumbnail Belinostat.svg?width=300.
- Q4882925 wikiPageWikiLink Q1367466.
- Q4882925 wikiPageWikiLink Q14901445.
- Q4882925 wikiPageWikiLink Q172341.
- Q4882925 wikiPageWikiLink Q3569101.
- Q4882925 wikiPageWikiLink Q415588.
- Q4882925 wikiPageWikiLink Q423762.
- Q4882925 wikiPageWikiLink Q5425270.
- Q4882925 wikiPageWikiLink Q640448.
- Q4882925 wikiPageWikiLink Q7168693.
- Q4882925 wikiPageWikiLink Q7427150.
- Q4882925 wikiPageWikiLink Q7667896.
- Q4882925 wikiPageWikiLink Q8515266.
- Q4882925 wikiPageWikiLink Q8824860.
- Q4882925 bioavailability "100.0".
- Q4882925 type ChemicalSubstance.
- Q4882925 type Drug.
- Q4882925 type ChemicalObject.
- Q4882925 type Thing.
- Q4882925 type Q8386.
- Q4882925 comment "Belinostat (trade name Beleodaq, previously known as PXD101) is a drug developed by TopoTarget for the treatment of hematological malignancies and solid tumors. It is a histone deacetylase inhibitor.In 2007 preliminary results were released from the Phase II clinical trial of intravenous belinostat in combination with carboplatin and paclitaxel for relapsed ovarian cancer.".
- Q4882925 label "Belinostat".
- Q4882925 depiction Belinostat.svg.
